Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OTX-DP for Dry Eye
NCT02468700Phase 2Completed
- Sponsor
- Ocular Therapeutix
- Start
- Jan 2015
- Primary completion
- Aug 2015
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of dexamethasone in dry eye disease (DED), sponsored by Ocular Therapeutix. Started Jan 2015; status: completed.
02
Drugs
dexamethasone
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT02468700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02468700.